1.0Reproductive Health Access Projecthttps://www.reproductiveaccess.orgReproductive Health Access Projecthttps://www.reproductiveaccess.org/author/reproductive-health-access-project/Removing Risk Evaluation and Mitigation Strategy (REMS) Categorization on Mifepristone - Reproductive Health Access Projectrich600338<blockquote class="wp-embedded-content" data-secret="IhZrQ5DjhD"><a href="https://www.reproductiveaccess.org/resource/removing-risk-evaluation-and-mitigation-strategy-rems-categorization-on-mifepristone/">Removing Risk Evaluation and Mitigation Strategy (REMS) Categorization on Mifepristone</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.reproductiveaccess.org/resource/removing-risk-evaluation-and-mitigation-strategy-rems-categorization-on-mifepristone/embed/#?secret=IhZrQ5DjhD" width="600" height="338" title="“Removing Risk Evaluation and Mitigation Strategy (REMS) Categorization on Mifepristone” — Reproductive Health Access Project" data-secret="IhZrQ5DjhD" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://www.reproductiveaccess.org/wp-content/uploads/2019/02/Resolution-No.-506-REMS_sm.jpeg85115A 2018 policy resolution calling for the AAFP to engage in efforts to overturn the Risk Evaluation and Mitigation Strategy (REMS) classification on Mifepristone. The resolution was adopted by the 2018 Congress of Delegates.